0001104659-21-114807.txt : 20210910
0001104659-21-114807.hdr.sgml : 20210910
20210910210100
ACCESSION NUMBER: 0001104659-21-114807
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210908
FILED AS OF DATE: 20210910
DATE AS OF CHANGE: 20210910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bertagnolli Monica
CENTRAL INDEX KEY: 0001761030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37990
FILM NUMBER: 211248359
MAIL ADDRESS:
STREET 1: C/O LEAP THERAPEUTICS, INC.
STREET 2: 47 THORNDIKE STREET, SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001509745
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274412575
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 252 4343
MAIL ADDRESS:
STREET 1: 47 THORNDIKE STREET
STREET 2: SUITE B1-1
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Dekkun Corp
DATE OF NAME CHANGE: 20110107
4
1
tm2127401-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-09-08
0
0001509745
LEAP THERAPEUTICS, INC.
LPTX
0001761030
Bertagnolli Monica
C/O LEAP THERAPEUTICS, INC.
47 THORNDIKE STREET SUITE B1-1
CAMBRIDGE
MA
02141
1
0
0
0
Stock Option (Right to Buy)
1.58
2021-09-08
4
A
0
65000
0
A
2031-09-07
Common Stock
65000
65000
D
Stock Option (Right to Buy)
1.58
2021-09-08
4
A
0
16150
0
A
2031-09-07
Common Stock
16150
16150
D
The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 12 equal quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 8, 2021, the Vesting Start Date.
The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable with respect to 50% of the Option on September 30, 2021, and with respect to the remaining 50% of the Option on December 31, 2021.
/s/ Douglas E. Onsi, as Attorney-in-Fact for Monica Bertagnolli
2021-09-10